Biochemical and Mutational Analysis of a Novel Nicotinamidase from Oceanobacillus iheyensis HTE831

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Sánchez Carrón, Guiomar ^a   García García, María Inmaculada ^a,b   Zapata Pérez, Rubén ^a   Takami, Hideto ^c   García Carmona, Francisco ^a,b   Sánchez Ferrer, Álvaro ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b Murcia Biomedical Research Institute (IMIB)   (Spain)

^c JAPAN AGENCY FOR MARINE EARTH SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL ENZYME; CYSTEINE; GLUTAMIC ACID; METAL ION; NICOTINAMIDASE; NICOTINAMIDE DERIVATIVE; PHENYLALANINE; PYRAZINAMIDASE; PYRAZINAMIDE; UNCLASSIFIED DRUG;

ALKALINITY; ARTICLE; BACILLALES; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MODIFICATION; ENZYME STRUCTURE; FIRMICUTES; METAL BINDING; MUTATIONAL ANALYSIS; NONHUMAN; OCEANOBACILLUS IHEYENSIS; PHYLOGENY; PROTEIN MOTIF; SALT TOLERANCE;

BACILLACEAE; NIACINAMIDE; NICOTINAMIDASE; PHYLOGENY; PYRAZINAMIDE; SUBSTRATE SPECIFICITY;

EID: 84874534775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056727     Document Type: Article

References (60)

1. French JB, Cen Y, Vrablik TL, Xu P, Allen E, et al. (2010) Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism. Biochemistry 49: 10421-10439.
2. Boshoff HI, Mizrahi V, (1998) Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis. J Bacteriol 180: 5809-5814.
3. Zhang H, Deng JY, Bi LJ, Zhou YF, Zhang ZP, et al. (2008) Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. FEBS J 275: 753-762.
4. Joshi JG, Handler P, (1962) Purification and properties of nicotinamidase from Torula cremoris. J Biol Chem 237: 929-935.
5. Hu G, Taylor AB, McAlister-Henn L, Hart PJ, (2007) Crystal structure of the yeast nicotinamidase Pnc1p. Arch Biochem Biophys 461: 66-75.
6. Ghislain M, Talla E, Francois JM, (2002) Identification and functional analysis of the Saccharomyces cerevisiae nicotinamidase gene, PNC1. Yeast 19: 215-224.
7. Scorpio A, Zhang Y, (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle Bacillus. Nat Med 2: 662-667.
8. Zerez CR, Roth EF Jr, Schulman S, Tanaka KR, (1990) Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood 75: 1705-1710.
9. Gazanion E, Garcia D, Silvestre R, Gerard C, Guichou JF, et al. (2011) The Leishmania nicotinamidase is essential for NAD(+) production and parasite proliferation. Mol Microbiol 82: 21-38.
10. Wang G, Pichersky E, (2007) Nicotinamidase participates in the salvage pathway of NAD biosynthesis in Arabidopsis. Plant J 49: 1020-1029.
11. Balan V, Miller GS, Kaplun L, Balan K, Chong ZZ, et al. (2008) Life span extension and neuronal cell protection by Drosophila nicotinamidase. J Biol Chem 283: 27810-27819.
12. van der Horst A, Schavemaker JM, Pellis-van Berkel W, Burgering BM, (2007) The Caenorhabditis elegans nicotinamidase PNC-1 enhances survival. Mech Ageing Dev 128: 346-349.
13. Belenky P, Bogan KL, Brenner C, (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32: 12-19.
14. Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, et al. (2003) A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol 48: 753-764.
15. Kawabata H, Norris SJ, Watanabe H, (2004) BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect Immun 72: 7147-7154.
16. Kim S, Kurokawa D, Watanabe K, Makino S, Shirahata T, et al. (2004) Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice. FEMS Microbiol Lett 234: 289-295.
17. Sauve AA, (2008) NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther 324: 883-893.
18. Gazanion E, Seblova V, Votypka J, Vergnes B, Garcia D, et al. (2012) Leishmania infantum nicotinamidase is required for late-stage development in its natural sand fly vector, Phlebotomus perniciosus. Int J Parasitol 42: 323-327.
19. Landry J, Slama JT, Sternglanz R, (2000) Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun 278: 685-690.
20. Tanny JC, Moazed D, (2001) Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product. Proc Natl Acad Sci U S A 98: 415-420.
21. Sauve AA, Moir RD, Schramm VL, Willis IM, (2005) Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol Cell 17: 595-601.
22. Avalos JL, Bever KM, Wolberger C, (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17: 855-868.
23. Sauve AA, Wolberger C, Schramm VL, Boeke JD, (2006) The biochemistry of sirtuins. Annu Rev Biochem 75: 435-465.
24. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA, (2003) Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423: 181-185.
25. Gallo CM, Smith DL Jr, Smith JS, (2004) Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol Cell Biol 24: 1301-1312.
26. Lin SJ, Defossez PA, Guarente L, (2000) Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
27. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Cohen H, et al. (2002) Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J Biol Chem 277: 18881-18890.
28. Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, et al. (2007) Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell 129: 473-484.
29. Belenky P, Christensen KC, Gazzaniga F, Pletnev AA, Brenner C, (2009) Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. J Biol Chem 284: 158-164.
30. Lin SJ, Ford E, Haigis M, Liszt G, Guarente L, (2004) Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev 18: 12-16.
31. de Oliveira RM, Sarkander J, Kazantsev AG, Outeiro TF, (2012) SIRT2 as a therapeutic target for age-related disorders. Front Pharmacol 3: 82.
32. Guarente L, (2011) Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med 364: 2235-2244.
33. Canto C, Auwerx J, (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev 64: 166-187.
34. Smith BC, Hallows WC, Denu JM, (2009) A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Anal Biochem 394: 101-109.
35. Du X, Wang W, Kim R, Yakota H, Nguyen H, et al. (2001) Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry 40: 14166-14172.
36. Fyfe PK, Rao VA, Zemla A, Cameron S, Hunter WN, (2009) Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide. Angew Chem Int Ed Engl 48: 9176-9179.
37. Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, et al. (2011) Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide. PLoS One 6: e15785.
38. Lu J, Nogi Y, Takami H, (2001) Oceanobacillus iheyensis gen. nov., sp. nov., a deep-sea extremely halotolerant and alkaliphilic species isolated from a depth of 1050 m on the Iheya Ridge. FEMS Microbiol Lett 205: 291-297.
39. Takami H, Takaki Y, Uchiyama I, (2002) Genome sequence of Oceanobacillus iheyensis isolated from the Iheya Ridge and its unexpected adaptive capabilities to extreme environments. Nucleic Acids Res 30: 3927-3935.
40. Sambrook J, Fritsch EP, Maniatis T (1989) Molecular Cloning: a Laboratory Manual New York: Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
41. Sanchez-Carron G, Garcia-Garcia MI, Lopez-Rodriguez AB, Jimenez-Garcia S, Sola-Carvajal A, et al. (2011) Molecular characterization of a novel N-acetylneuraminate lyase from Lactobacillus plantarum WCFS1. Appl Environ Microbiol 77: 2471-2478.
42. Davies GE, Stark GR, (1970) Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. Proc Natl Acad Sci U S A 66: 651-656.
43. Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P, (2006) Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem 357: 289-298.
44. Murphy DJ, (2004) Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design. Anal Biochem 327: 61-67.
45. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
46. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
47. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
48. Gouet P, Courcelle E, Stuart DI, Metoz F, (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
49. Combet C, Jambon M, Deleage G, Geourjon C, (2002) Geno3D: automatic comparative molecular modelling of protein. Bioinformatics 18: 213-214.
50. Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, et al. (2011) ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res 39: D465-474.
51. Finn RD, Clements J, Eddy SR, (2011) HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 39: W29-37.
52. consortium TU, (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40: D71-75.
53. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
54. French JB, Cen Y, Sauve AA, Ealick SE, (2010) High-resolution crystal structures of Streptococcus pneumoniae nicotinamidase with trapped intermediates provide insights into the catalytic mechanism and inhibition by aldehydes. Biochemistry 49: 8803-8812.
55. Pardee AB, Benz EJ Jr, St Peter DA, Krieger JN, Meuth M, et al. (1971) Hyperproduction and purification of nicotinamide deamidase, a microconstitutive enzyme of Escherichia coli. J Biol Chem 246: 6792-6796.
56. Yan C, Sloan DL, (1987) Purification and characterization of nicotinamide deamidase from yeast. J Biol Chem 262: 9082-9087.
57. Kruger D, Schauer R, Traving C, (2001) Characterization and mutagenesis of the recombinant N-acetylneuraminate lyase from Clostridium perfringens: insights into the reaction mechanism. Eur J Biochem 268: 3831-3839.
58. Tanigawa Y, Shimoyama M, Ueda I, (1980) Nicotinamide deamidase from Flavobacterium peregrinum. Methods Enzymol 66: 132-136.
59. Zhang JL, Zheng QC, Li ZQ, Zhang HX, (2012) Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase. PLoS One 7: e39546.
60. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.